A newly identified mutation dramatically raises prostate cancer risk in Ashkenazi Jewish men and may increase sensitivity to ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced longer-term follow-up results from an open-label extension of the Phase 3 ARCHES ...

Clinically-Inspired Formula Combats Urinary Urgency, Boosts Vitality, and Supports Prostate Health with Scientifically-Backed ...

The UCSF study also promotes eating fruits and vegetables to lower the risk of prostate cancer because of the vitamins, ...

A diabetes drug may hold the key to preventing prostate cancer relapse. Scientists discovered that prostate cancer patients ...

Experts explain the science behind Biden's advanced prostate cancer diagnosis, including how common it is and what treatments are available.

Researchers say, “It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while they’re fighting tumors.” ...